Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982 Jun;13(6):855–858. doi: 10.1111/j.1365-2125.1982.tb01878.x

Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.

A B Atkinson, A M Cumming, J J Brown, R Fraser, B Leckie, A F Lever, J J Morton, J I Robertson
PMCID: PMC1402024  PMID: 7046776

Abstract

1 The ability of captopril, 150 mg three times daily by mouth, to effect sustained reduction in plasma angiotensin II, with converse increases in circulating angiotensin I, and in active, inactive and total renin concentrations, has been assessed. 2 During prolonged treatment with captopril alone, and 12 h after the last dose of the drug, plasma angiotensin II remained approximately one-sixth of basal concentrations, while angiotensin I and renin concentrations were proportionately increased. However, further increases in angiotensin I, and in active, inactive and total renin concentrations, were seen 2 and 6 h after the morning dose of 150 mg captopril. 3 Inter-dose variations in plasma aldosterone and blood pressure were not closely related to concurrent variations in the renin-angiotensin system. 4 Arguments are presented for relying on measurements of plasma renin and angiotensin concentrations rather than of renin activity or aldosterone in assessing the effectiveness of converting enzyme inhibition.

Full text

PDF
855

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkinson A. B., Brown J. J., Cumming A. M., Fraser R., Lever A. F., Leckie B. J., Morton J. J., Robertson J. I. Captopril in renovascular hypertension: long-term use in predicting surgical outcome. Br Med J (Clin Res Ed) 1982 Mar 6;284(6317):689–693. doi: 10.1136/bmj.284.6317.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Atkinson A. B., Morton J. J., Brown J. J., Davies D. L., Fraser R., Kelly P., Leckie B., Lever A. F., Robertson J. I. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. Br Heart J. 1980 Sep;44(3):290–296. doi: 10.1136/hrt.44.3.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Atkinson A. B., Robertson J. I. Captopril in the treatment of clinical hypertension and cardiac failure. Lancet. 1979 Oct 20;2(8147):836–839. doi: 10.1016/s0140-6736(79)92186-x. [DOI] [PubMed] [Google Scholar]
  4. Atlas S. A., Case D. B., Sealey J. E., Laragh J. H., McKinstry D. N. Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis. Hypertension. 1979 May-Jun;1(3):274–280. doi: 10.1161/01.hyp.1.3.274. [DOI] [PubMed] [Google Scholar]
  5. Bean B. L., Brown J. J., Casals-Stenzel J., Fraser R., Lever A. F., Millar J. A., Morton J. J., Petch B., Riegger A. J., Robertson J. I. The relation of arterial pressure and plasma angiotensin II concentration. A change produced by prolonged infusion of angiotensin II in the conscious dog. Circ Res. 1979 Apr;44(4):452–458. doi: 10.1161/01.res.44.4.452. [DOI] [PubMed] [Google Scholar]
  6. Boomsma F., de Bruyn J. H., Derkx F. H., Schalekamp M. A. Opposite effects of captopril on angiotensin I-converting enzyme 'activity' and 'concentration'; relation between enzyme inhibition and long-term blood pressure response. Clin Sci (Lond) 1981 May;60(5):491–498. doi: 10.1042/cs0600491. [DOI] [PubMed] [Google Scholar]
  7. Brown A. J., Casals-Stenzel J., Gofford S., Lever A. F., Morton J. J. Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. Am J Physiol. 1981 Sep;241(3):H381–H388. doi: 10.1152/ajpheart.1981.241.3.H381. [DOI] [PubMed] [Google Scholar]
  8. DICKINSON C. J., LAWRENCE J. R. A slowly developing pressor response to small concentrations of angiotensin. Its bearing on the pathogenesis of chronic renal hypertension. Lancet. 1963 Jun 22;1(7295):1354–1356. doi: 10.1016/s0140-6736(63)91929-9. [DOI] [PubMed] [Google Scholar]
  9. Düsterdieck G., McElwee G. Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states. Eur J Clin Invest. 1971 Nov;2(1):32–38. doi: 10.1111/j.1365-2362.1971.tb00565.x. [DOI] [PubMed] [Google Scholar]
  10. Fraser R., Brown J. J., Lever A. F., Mason P. A., Robertson J. I. Control of aldosterone secretion. Clin Sci (Lond) 1979 May;56(5):389–399. doi: 10.1042/cs0560389. [DOI] [PubMed] [Google Scholar]
  11. Fraser R., Guest S., Young J. A comparison of double-isotope derivative and radioimmunological estimation of plasma aldosterone concentration in man. Clin Sci Mol Med. 1973 Sep;45(3):411–415. doi: 10.1042/cs0450411. [DOI] [PubMed] [Google Scholar]
  12. Khayyall M., MacGregor J., Brown J. J., Lever A. F., Robertson J. I. Increase of plasma renin-substrate concentration after infusion of angiotensin in the rat. Clin Sci. 1973 Jan;44(1):87–90. doi: 10.1042/cs0440087. [DOI] [PubMed] [Google Scholar]
  13. Maslowski A. H., Nicholls M. G., Ikram H., Espiner E. A., Turner J. G. Haemodynamic, hormonal, and electrolyte responses to withdrawal of long-term captopril treatment for heart failure. Lancet. 1981 Oct 31;2(8253):959–961. doi: 10.1016/s0140-6736(81)91157-0. [DOI] [PubMed] [Google Scholar]
  14. Millar J. A., Leckie B. J., Morton J. J., Jordan J., Tree M. A microassay for active and total renin concentration in human plasma based on antibody trapping. Clin Chim Acta. 1980 Feb 14;101(1):5–15. doi: 10.1016/0009-8981(80)90050-9. [DOI] [PubMed] [Google Scholar]
  15. Rasmussen S., Damkjaer Nielsen M., Giese J. Captopril combined with thiazide lowers renin substrate concentration: implications for methodology in renin assays. Clin Sci (Lond) 1981 May;60(5):591–593. doi: 10.1042/cs0600591. [DOI] [PubMed] [Google Scholar]
  16. Roulston J. E., MacGregor G. A. The measurement of angiotensin-converting enzyme in subjects receiving captopril. N Engl J Med. 1980 Aug 14;303(7):397–397. doi: 10.1056/NEJM198008143030717. [DOI] [PubMed] [Google Scholar]
  17. Waeber B., Brunner H. R., Brunner D. B., Curtet A. L., Turini G. A., Gavras H. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril. Hypertension. 1980 Mar-Apr;2(2):236–242. doi: 10.1161/01.hyp.2.2.236. [DOI] [PubMed] [Google Scholar]
  18. Waite M. A. Measurement of concentrations of angiotensin I in human blood by radioimmunoassay. Clin Sci. 1973 Jul;45(1):51–64. doi: 10.1042/cs0450051. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES